IPSC News

The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL) priced at the midpoint to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and...read more

Century Therapeutics, a preclinical biotech developing allogenic stem cell treatments for multiple cancers, raised $211 million by offering 10.6 million shares at $20, the high end of the range of $18 to $20. Century Therapeutics is developing an allogenic stem cell platform that allows it to incorporate multiple transgenes and remove target genes to optimize cell product...read more

Century Therapeutics, a preclinical biotech developing allogenic stem cell treatments for multiple cancers, announced terms for its IPO on Monday. The Philadelphia, PA-based company plans to raise $200 million by offering 10.6 million shares at a price range of $18 to $20. At the midpoint of the proposed range, Century Therapeutics would command a fully diluted market value of...read more

Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and epigenetic reprogramming to develop T...read more